D2 dopamine receptors have been implicated in neuropsychiatric and neurologic disorders including schizophrenia, drug abuse, and Parkinson's disease. Acute activation of D2 dopamine receptors inhibits cyclic AMP accumulation;however, persistent activation of D2 dopamine receptors enhances subsequent drug-stimulated cyclic AMP accumulation. This heterologous sensitization of adenylyl cyclase (AC) signaling occurs following persistent activation of several G?i/o-coupled receptors in vitro and in vivo. The overall objective of this research proposal is to elucidate the molecular mechanisms involved in heterologous sensitization of AC following persistent activation of D2-like dopamine receptors. Previous studies support a hypothesis that heterologous sensitization requires the activation of G?i/o subunits to induce sensitization through a G??-dependent mechanism. We hypothesize that G?? subunits lead to heterologous sensitization of individual AC isoforms through both direct and indirect mechanisms. The indirect mechanisms may involve protein-protein interactions as well as G?s. The general approach for these studies will be to express heterologously D2L dopamine receptors together with well characterized wild-type or mutant ACs (e.g. AC1, AC2, and AC5) for intact cell experiments in unique cellular backgrounds (i.e., G protein subunit deficient). This strategy takes advantage of recently discovered molecular and cellular tools to study G protein signaling as well as novel fluorescent technologies. The first specific aim will test the hypothesis that heterologous sensitization of select isoforms of AC involves G??-AC interactions and requires G?? subunit signaling. These studies will use a series of AC mutants, unique cellular models, small molecule inhibitors of G?? subunit signaling, and striatal neurons. The second specific aim will determine the roles and requirements for G protein subunits in modulating receptor-AC and AC-AC interactions. These experiments will use bimolecular fluorescence complementation (BiFC) to probe the specific role of G?? and G?s subunits in modulating basal and drug-induced protein-protein interactions in living cells. The third specific aim will identify and characterize the AC """"""""sensitization interactome"""""""" using BiFC in a neuronal cell model. These studies will use BiFC to perform cDNA library screening to identify sensitization-induced interacting proteins of AC in living cells. Completion of the proposed studies will deliver mechanistic information regarding specific G protein subunits and new protein targets that could ultimately be used to prevent the development and expression of heterologous sensitization in vivo.

Public Health Relevance

Understanding the molecular mechanisms responsible for D2 dopamine receptor-induced sensitization of adenylyl cyclase has implications in a variety of diseases including schizophrenia, Parkinson's disease, and drug abuse. Sensitization of adenylyl cyclase signaling occurs following persistent activation of several G?i/o-coupled receptors. Thus, the information discovered here is also relevant to many G protein-coupled receptors that are targets of drugs used to treat pain, depression, and Alzheimer's disease (e.g., opioid, serotonin, and muscarinic receptors).

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
2R01MH060397-10A1
Application #
8107335
Study Section
Molecular Neuropharmacology and Signaling Study Section (MNPS)
Program Officer
Nadler, Laurie S
Project Start
2000-05-10
Project End
2013-05-31
Budget Start
2011-08-15
Budget End
2012-05-31
Support Year
10
Fiscal Year
2011
Total Cost
$406,138
Indirect Cost
Name
Purdue University
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
072051394
City
West Lafayette
State
IN
Country
United States
Zip Code
47907
Brust, Tarsis F; Alongkronrusmee, Doungkamol; Soto-Velasquez, Monica et al. (2017) Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties. Sci Signal 10:
Brust, Tarsis F; Hayes, Michael P; Roman, David L et al. (2015) New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated G?? signaling. Biochem Pharmacol 93:85-91
Brust, Tarsis F; Conley, Jason M; Watts, Val J (2015) G?(i/o)-coupled receptor-mediated sensitization of adenylyl cyclase: 40 years later. Eur J Pharmacol 763:223-32
Brust, Tarsis F; Hayes, Michael P; Roman, David L et al. (2015) Bias analyses of preclinical and clinical D2 dopamine ligands: studies with immediate and complex signaling pathways. J Pharmacol Exp Ther 352:480-93
Conley, Jason M; Brust, Tarsis F; Xu, Ruqiang et al. (2014) Drug-induced sensitization of adenylyl cyclase: assay streamlining and miniaturization for small molecule and siRNA screening applications. J Vis Exp :e51218
Staffend, Nancy A; Hedges, Valerie L; Chemel, Benjamin R et al. (2014) Cell-type specific increases in female hamster nucleus accumbens spine density following female sexual experience. Brain Struct Funct 219:2071-81
Conley, Jason M; Watts, Val J (2013) Differential effects of AGS3 expression on D(2L) dopamine receptor-mediated adenylyl cyclase signaling. Cell Mol Neurobiol 33:551-8
Brand, Cameron S; Hocker, Harrison J; Gorfe, Alemayehu A et al. (2013) Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds. J Pharmacol Exp Ther 347:265-75
Ejendal, Karin F K; Conley, Jason M; Hu, Chang-Deng et al. (2013) Bimolecular fluorescence complementation analysis of G protein-coupled receptor dimerization in living cells. Methods Enzymol 521:259-79
Conley, Jason M; Brand, Cameron S; Bogard, Amy S et al. (2013) Development of a high-throughput screening paradigm for the discovery of small-molecule modulators of adenylyl cyclase: identification of an adenylyl cyclase 2 inhibitor. J Pharmacol Exp Ther 347:276-87

Showing the most recent 10 out of 50 publications